Dr. Amparo Santamaria joins Dr. Evgeniy Galimov to discuss her research paper, titled “Enhancing oocyte activation in women with ovarian failure: clinical outcomes of the Stem Cell Regenera study using G-CSF mobilization of peripheral blood stem cells and intraovarian injection of stem cell factor-enriched platelet rich plasma in real-world-practice.”
Aging-US Authors
Federica Grosso describes a research paper she co-authored that was published in Volume 17, Issue 8, entitled “Causal relationships between gut microbiome and hundreds of age-related traits: evidence of a replicable effect on ApoM protein levels.”
Dr. Leonard Egede, Dr. Rebekah Walker, and Dr. Obinna Ekwunife from the University of Buffalo, NY, describe their research paper published in Volume 17, Issue 8, titled “Longitudinal relationship between social and CVD risk factors in older adults with prediabetes: the HRS 2006-2016.”
Girish Harinath from AgelessRx joins host Dr. Evgeniy Galimov to discuss a research paper he co-authored in Volume 17, Issue 4 of Aging-US, titled “Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results.”
Dr. Amparo Santamaria describes a her research paper, titled “Enhancing oocyte activation in women with ovarian failure: clinical outcomes of the Stem Cell Regenera study using G-CSF mobilization of peripheral blood stem cells and intraovarian injection of stem cell factor-enriched platelet rich plasma in real-world-practice.”
Dr. Andres Cardenas joins host Dr. Evgeniy Galimov to discuss “Exposome-wide association study of environmental chemical exposures and epigenetic aging in the National Health and Nutrition Examination Survey.”
Dr. Josh Mitteldorf summarizes his research perspective published in Volume 17, Issue 5 of Aging (Aging-US), titled “Methylation clocks for evaluation of anti-aging interventions.”
Dr. Stefanie Morgan joins Dr. Robert Dudley from AgelessRx to discuss a research paper she co-authored in Aging, entitled “Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results.”
Dr. Shubhankar Suman from the Department of Oncology at Georgetown University Medical Center joins host Dr. Evgeniy Galimov to discuss a research paper he co-authored in Volume 17, Issue 1 of Aging (Aging-US), titled: “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.”
Dr. Stephen Vatner from Rutgers New Jersey Medical School, joins host Dr. Evgeniy Galimov to discuss a research perspective he co-authored in Volume 16, Issue 22 of Aging (Aging-US), titled “Brown adipose tissue enhances exercise performance and healthful longevity.”